Calculating the prevalence of soil-transmitted helminth infection through pooling of stool samples: Choosing and optimizing the pooling strategy
Author(s)
Type
Journal Article
Abstract
Prevalence is a common epidemiological measure for assessing soil-transmitted helminth
burden and forms the basis for much public-health decision-making. Standard diagnostic
techniques are based on egg detection in stool samples through microscopy and these techniques are known to have poor sensitivity for individuals with low infection intensity, leading
to poor sensitivity in low prevalence populations. PCR diagnostic techniques offer very high
sensitivities even at low prevalence, but at a greater cost for each diagnostic test in terms of
equipment needed and technician time and training. Pooling of samples can allow prevalence to be estimated while minimizing the number of tests performed. We develop a model
of the relative cost of pooling to estimate prevalence, compared to the direct approach of
testing all samples individually. Analysis shows how expected relative cost depends on both
the underlying prevalence in the population and the size of the pools constructed. A critical
prevalence level (approx. 31%) above which pooling is never cost effective, independent of
pool size. When no prevalence information is available, there is no basis on which to choose
between pooling and testing all samples individually. We recast our model of relative cost in
a Bayesian framework in order to investigate how prior information about prevalence in a
given population can be used to inform the decision to choose either pooling or full testing.
Results suggest that if prevalence is below 10%, a relatively small exploratory prevalence
survey (10–15 samples) can be sufficient to give a high degree of certainty that pooling may
be relatively cost effective.
burden and forms the basis for much public-health decision-making. Standard diagnostic
techniques are based on egg detection in stool samples through microscopy and these techniques are known to have poor sensitivity for individuals with low infection intensity, leading
to poor sensitivity in low prevalence populations. PCR diagnostic techniques offer very high
sensitivities even at low prevalence, but at a greater cost for each diagnostic test in terms of
equipment needed and technician time and training. Pooling of samples can allow prevalence to be estimated while minimizing the number of tests performed. We develop a model
of the relative cost of pooling to estimate prevalence, compared to the direct approach of
testing all samples individually. Analysis shows how expected relative cost depends on both
the underlying prevalence in the population and the size of the pools constructed. A critical
prevalence level (approx. 31%) above which pooling is never cost effective, independent of
pool size. When no prevalence information is available, there is no basis on which to choose
between pooling and testing all samples individually. We recast our model of relative cost in
a Bayesian framework in order to investigate how prior information about prevalence in a
given population can be used to inform the decision to choose either pooling or full testing.
Results suggest that if prevalence is below 10%, a relatively small exploratory prevalence
survey (10–15 samples) can be sufficient to give a high degree of certainty that pooling may
be relatively cost effective.
Date Issued
2019-03-21
Date Acceptance
2019-01-29
Citation
PLoS Neglected Tropical Diseases, 2019, 13 (3)
ISSN
1935-2727
Publisher
Public Library of Science
Journal / Book Title
PLoS Neglected Tropical Diseases
Volume
13
Issue
3
Copyright Statement
© 2019 Truscott et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
access article distributed under the terms of the
Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Sponsor
Bill & Melinda Gates Foundation
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463799300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
SON15004
Subjects
Science & Technology
Life Sciences & Biomedicine
Infectious Diseases
Parasitology
Tropical Medicine
EGG COUNTS
SCHISTOSOMA-MANSONI
SENSITIVITY
DIAGNOSIS
INTENSITY
Publication Status
Published
Article Number
e0007196
Date Publish Online
2019-03-21